Hemofarm a.d. (full legal name: ''Hemofarm

a.d. The terms (AD) and before Christ (BC) are used to label or number years in the Julian and Gregorian calendars. The term is Medieval Latin and means 'in the year of the Lord', but is often presented using "our Lord" instead of "the Lord", ...

'' Farmaceutsko-hemijska industrija Vršac), a member of STADA Group, is a Serbian

pharmaceutical company The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered to patients (or self-administered), with the aim to cure them, vaccinate them, or alleviate sympto ...

based in

Vršac Vršac ( sr-cyr, Вршац, ; hu, Versec; ro, Vârșeț) is a city and the administrative centre of the South Banat District in the autonomous province of Vojvodina, Serbia. As of 2011, the city urban area had a population of 35,701, while ...

Serbia Serbia (, ; Serbian: , , ), officially the Republic of Serbia (Serbian: , , ), is a landlocked country in Southeastern and Central Europe, situated at the crossroads of the Pannonian Basin and the Balkans. It shares land borders with Hungar ...

. Founded in 1960, it is one of the largest domestic producer and exporter of medicines in Serbia. Hemofarm currently operates in more than 30 countries on 3 continents and has around 3,000 employees. The core activity represents the manufacture of Rx and OTC medicines and products. The portfolio includes over 140 INNs, with about 280 forms and dosage forms.

History

Hemofarm was established on 1 June 1960 in

. In 2003, it opened the first factory for the production of medicine in entity Republika Srpska,

Bosnia and Herzegovina Bosnia and Herzegovina ( sh, / , ), abbreviated BiH () or B&H, sometimes called Bosnia–Herzegovina and often known informally as Bosnia, is a country at the crossroads of south and southeast Europe, located in the Balkans. Bosnia and H ...

. As of 2003, Hemofarm consisted of 21 subsidiaries, 12 of which were located in

and the rest in

Montenegro ) , image_map = Europe-Montenegro.svg , map_caption = , image_map2 = , capital = Podgorica , coordinates = , largest_city = capital , official_languages = M ...

. In 2004, the company acquired four other Serbian concerns, increasing its market share from 15% to 45% in the process. As of 2011, the company has a market share in terms of production and import of 30.7%. Hemofarm was bought by the German

STADA Arzneimittel Stada Arzneimittel AG is a pharmaceutical company based in Bad Vilbel, Germany which specializes in the production of generic and over-the-counter drugs. In 2018, revenue totaled €2.33 billion. Commonly known products produced by Stada are Sta ...

pharmaceutical group for 480 million

euro The euro ( symbol: €; code: EUR) is the official currency of 19 out of the member states of the European Union (EU). This group of states is known as the eurozone or, officially, the euro area, and includes about 340 million citizens . ...

s in 2006. Since 9 August 2009 Hemofarm has been a member of the German STADA Group. In August 2016, Hemofarm bought the assets of a Serbian minor pharmaceutical company "Ivančić i sinovi" for undisclosed amount.

Research and development

Hemofarm’s R&D division was established in 1990, and it has been recognized by STADA as a competence center for development of new generic products not only for local and regional markets, but also for the whole STADA Group. An intensive development of products intended for registration and sale in the demanding

European Union The European Union (EU) is a supranational political and economic union of member states that are located primarily in Europe. The union has a total area of and an estimated total population of about 447million. The EU has often been de ...

market started in 2007.

References

External links

*
Official Stada group website
1960 establishments in Serbia 2006 mergers and acquisitions Companies based in Vršac Economy of Vojvodina Pharmaceutical companies established in 1960 Pharmaceutical companies of Serbia Serbian brands {{Serbia-company-stub